Brain Cancer Trial, Recruiting NCT06967285 Sponsor: Sichuan Provincial People's Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06967285
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with Acute Respiratory Distress Syndrome (ARDS), a serious lung condition, where oxygen levels in the blood are severely low (PaO₂/FiO₂ below 150 mmHg), and who require treatment where they are turned face-down (prone positioning) while on a breathing machine
  • People who are expected to need a breathing machine for more than 48 hours
  • People who have given written consent to participate in the trial

Who may not be able to join:

  • People for whom lying face-down is not safe, for example due to head or neck injuries, an unstable spine, or dangerously high pressure in the brain
  • People with serious brain or neurological conditions — such as bleeding in the brain, stroke, or brain tumours — that could interfere with monitoring of blood flow to the brain
  • People whose ARDS is immediately life-threatening
  • People who are unable to undergo brain and nervous system assessments
  • People for whom the monitoring equipment produces poor or no usable images (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: lingai Pan, PhD, Sichuan Provincial People's Hospital

Phone: 17708130236

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sichuan Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
19 March 2025
Est. completion
1 April 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Neuroimaging Studies; Biomarker Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov